BP885

Etoposide

British Pharmacopoeia (BP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 33419-42-0

Synonym(S): 4′-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside), VP-16-213

Select a Size

Pack Size SKU Availability Price
150 MG BP885-150-MG In Stock ₹ 23,944.90

BP885 - 150 MG

₹ 23,944.90

In Stock

Quantity

1

Base Price: ₹ 23,944.90

GST (18%): ₹ 4,310.082

Total Price: ₹ 28,254.982

grade

pharmaceutical primary standard

API family

etoposide

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceuticalpharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26

InChI

1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1

Related Products

Img

Sigma Aldrich

BP804

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP894

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP768

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP793

British Pharmacopoeia (BP) Referenc...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Etoposide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Etoposide Oral SolutionEtoposide CapsulesEtoposide Infusion
  • Biochem/physiol Actions: Etoposide is an antitumor agent that complexes with topoisomerase II and DNA to enhance double-strand and single-strand cleavage of DNA and reversibly inhibit religation. Blocks the cell cycle in in S-phase and G2-phase of the cell cycle; induces apoptosis in normal and tumor cell lines; inhibits synthesis of the oncoprotein Mdm2 and induces apoptosis in tumor lines that overexpress Mdm2.
  • Packaging: Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS08,GHS07

Signal Word

Danger

Hazard Statements

H302,H350,H361d

Precautionary Statements

P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Repr. 2

WGK

WGK 3